OBJECTIVE: The aim of this study was to analyse change in the health status of the population in the countries of Central and Eastern Europe (CEE) since 1990, compared with the 'old' EU-15 member states of the European Union (EU). METHODS: We analysed data from the Health for All Database and the Global Burden of Disease report of the World Health Organization (WHO). Life expectancy at birth and disability-adjusted life years were analysed for 1990-2010. Age-standardised death rates (ASDR) and potential years of life lost (PYLL) were assessed for selected inflammatory diseases. RESULTS: Life expectancy at birth for male individuals improved in CEE by 4.8 years and in the EU-15 by 5.4 years. During the same period, life expectancy at birth for female individuals improved in CEE by 4.0 years and in the EU-15 by 4.2 years. The difference in life expectancy at birth between male and female individuals in the EU-15 decreased by 1.2 years and in CEE by 0.8 years. Comparisons of ASDR and PYLL among the EU-15 and CEE countries were difficult because of the potentially low validity of the available data. CONCLUSIONS: The health status of the CEE population has improved since 1990. However, only a few countries have closed the gap with the EU-15 countries. Inflammatory conditions might represent a significant disease burden in CEE countries; however, a thorough analysis and comparison to the EU-15 is difficult because of a shortage of good-quality data.
OBJECTIVE: The aim of this study was to analyse change in the health status of the population in the countries of Central and Eastern Europe (CEE) since 1990, compared with the 'old' EU-15 member states of the European Union (EU). METHODS: We analysed data from the Health for All Database and the Global Burden of Disease report of the World Health Organization (WHO). Life expectancy at birth and disability-adjusted life years were analysed for 1990-2010. Age-standardised death rates (ASDR) and potential years of life lost (PYLL) were assessed for selected inflammatory diseases. RESULTS: Life expectancy at birth for male individuals improved in CEE by 4.8 years and in the EU-15 by 5.4 years. During the same period, life expectancy at birth for female individuals improved in CEE by 4.0 years and in the EU-15 by 4.2 years. The difference in life expectancy at birth between male and female individuals in the EU-15 decreased by 1.2 years and in CEE by 0.8 years. Comparisons of ASDR and PYLL among the EU-15 and CEE countries were difficult because of the potentially low validity of the available data. CONCLUSIONS: The health status of the CEE population has improved since 1990. However, only a few countries have closed the gap with the EU-15 countries. Inflammatory conditions might represent a significant disease burden in CEE countries; however, a thorough analysis and comparison to the EU-15 is difficult because of a shortage of good-quality data.
Authors: Valentin Brodszky; Péter Bálint; Pál Géher; László Hodinka; Gábor Horváth; Éva Koó; Márta Péntek; Anna Polgár; Magdolna Seszták; Sándor Szántó; Ilona Ujfalussy; László Gulácsi Journal: Rheumatol Int Date: 2009-12 Impact factor: 2.631
Authors: João Vasco Santos; Mariana Lobo; Rui Manuel Neiva; João Viana; Júlio Souza; Cláudia Camila Dias; Jonathan Cylus; Walter Ricciardi; Alberto Freitas Journal: Int J Public Health Date: 2020-02-17 Impact factor: 3.380
Authors: Fanni Rencz; Ágnes Kovács; Valentin Brodszky; László Gulácsi; Zalán Németh; Gábor János Nagy; János Nagy; István Buzogány; Géza Böszörményi-Nagy; Attila Majoros; Péter Nyirády Journal: Int Urol Nephrol Date: 2015-06-21 Impact factor: 2.370
Authors: Cs Zoltán Horváth; Andor Sebestyén; August Österle; Dóra Endrei; József Betlehem; András Oláh; László Imre; Gabriella Bagosi; Imre Boncz Journal: Eur J Health Econ Date: 2014-05-16
Authors: Ildikó Ádám; Marcelien Callenbach; Bertalan Németh; Rick A Vreman; Cecilia Tollin; Johan Pontén; Dalia Dawoud; Jamie Elvidge; Nick Crabb; Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Anke Pisters-van Roy; Áron Vincziczki; Emad Almomani; Maja Vajagic; Z Gulsen Oner; Mirna Matni; Jurij Fürst; Rabia Kahveci; Wim G Goettsch; Zoltán Kaló Journal: Front Med (Lausanne) Date: 2022-09-23
Authors: Zoltán Kaló; Adrian Gheorghe; Mirjana Huic; Marcell Csanádi; Finn Boerlum Kristensen Journal: Health Econ Date: 2016-01-14 Impact factor: 3.046
Authors: Alexandra Makai; Kata Füge; Zita Breitenbach; József Betlehem; Pongrác Ács; Kinga Lampek; Mária Figler Journal: BMC Public Health Date: 2020-08-17 Impact factor: 3.295